Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comment on "Review of patient registries in dermatology".
Zweegers J, Bronckers IM, van den Reek JM, van Geel MJ, van de Kerkhof PC, Seyger MM, de Jong EM. Zweegers J, et al. J Am Acad Dermatol. 2016 Dec;75(6):e241. doi: 10.1016/j.jaad.2016.05.051. J Am Acad Dermatol. 2016. PMID: 27846976 No abstract available.
Drug Survival Studies in Dermatology:Principles, Purposes, and Pitfalls.
van den Reek JMPA, Kievit W, Gniadecki R, Goeman JJ, Zweegers J, van de Kerkhof PCM, Seyger MMB, de Jong EMGJ. van den Reek JMPA, et al. Among authors: zweegers j. J Invest Dermatol. 2015 Jul;135(7):1-5. doi: 10.1038/jid.2015.171. J Invest Dermatol. 2015. PMID: 26066896 Free article. Review. No abstract available.
Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network.
van den Reek JM, van Lüumig PP, Otero ME, Zweegers J, van de Kerkhof PC, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Seyger MM, Kievit W, de Jong EM. van den Reek JM, et al. Among authors: zweegers j. Br J Dermatol. 2014 May;170(5):1158-65. doi: 10.1111/bjd.12862. Br J Dermatol. 2014. PMID: 24484403
Summary of the Dutch S3-guidelines on the treatment of psoriasis 2011. Dutch Society of Dermatology and Venereology.
Zweegers J, de Jong EM, Nijsten TE, de Bes J, te Booij M, Borgonjen RJ, van Cranenburgh OD, van Deutekom H, van Everdingen JJ, de Groot M, Van Hees CL, Hulshuizen H, Koek MB, de Korte WJ, de Korte J, Lecluse LL, Pasch MC, Poblete-Gutiérrez PA, Prens EP, Seyger MM, Thio HB, Torcque LA, de Vries AC, van de Kerkhof PC, Spuls PI. Zweegers J, et al. Dermatol Online J. 2014 Mar 17;20(3):doj_21769. Dermatol Online J. 2014. PMID: 24656281 Free article.
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.
van den Reek JM, Zweegers J, Kievit W, Otero ME, van Lümig PP, Driessen RJ, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, van de Kerkhof PC, Seyger MM, de Jong EM. van den Reek JM, et al. Among authors: zweegers j. Br J Dermatol. 2014 Nov;171(5):1189-96. doi: 10.1111/bjd.13087. Epub 2014 Oct 3. Br J Dermatol. 2014. PMID: 24807471
Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: BioCAPTURE.
Zweegers J, van den Reek JM, van de Kerkhof PC, Otero ME, Ossenkoppele PM, Njoo MD, Mommers JM, Koetsier MI, Arnold WP, Sybrandy-Fleuren BA, Kuijpers AL, Andriessen MP, Kievit W, de Jong EM. Zweegers J, et al. Br J Dermatol. 2014 Nov;171(5):1091-8. doi: 10.1111/bjd.13137. Epub 2014 Oct 20. Br J Dermatol. 2014. PMID: 24861358
Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry.
Zweegers J, van den Reek JM, van de Kerkhof PC, Otero ME, Kuijpers AL, Koetsier MI, Arnold WP, Berends MA, Weppner-Parren L, Ossenkoppele PM, Njoo MD, Mommers JM, van Lümig PP, Driessen RJ, Kievit W, de Jong EM. Zweegers J, et al. Br J Dermatol. 2016 Aug;175(2):340-7. doi: 10.1111/bjd.14552. Epub 2016 Jun 25. Br J Dermatol. 2016. PMID: 26989852
Polymorphisms in CD84, IL12B and TNFAIP3 are associated with response to biologics in patients with psoriasis.
van den Reek JMPA, Coenen MJH, van de L'Isle Arias M, Zweegers J, Rodijk-Olthuis D, Schalkwijk J, Vermeulen SH, Joosten I, van de Kerkhof PCM, Seyger MMB, Zeeuwen PLJM, de Jong EMGJ. van den Reek JMPA, et al. Among authors: zweegers j. Br J Dermatol. 2017 May;176(5):1288-1296. doi: 10.1111/bjd.15005. Epub 2017 Apr 10. Br J Dermatol. 2017. PMID: 27564082
Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry.
Zweegers J, Groenewoud JMM, van den Reek JMPA, Otero ME, van de Kerkhof PCM, Driessen RJB, van Lümig PPM, Njoo MD, Ossenkoppele PM, Mommers JM, Koetsier MIA, Arnold WP, Andriessen MPM, Kuijpers ALA, Berends MAM, Kievit W, de Jong EMGJ. Zweegers J, et al. Br J Dermatol. 2017 Apr;176(4):1001-1009. doi: 10.1111/bjd.15023. Epub 2017 Mar 10. Br J Dermatol. 2017. PMID: 27579864
23 results